Diabetes mellitus after renal transplantation: As deleterious as non- transplant-associated diabetes?

Transplantation

Volumn 65, Issue 3, 1998, Pages 380-384

  Miles, Anne Marie V ^a   Sumrani, Nabil ^a   Horowitz, Robin ^a   Homel, Peter ^a   Maursky, Victoria ^a   Markell, Mariana S ^a   Distant, Dale A ^a   Hong, Joon H ^a   Sommer, Bruce G ^a   Friedman, Eli A ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CREATININE; CYCLOSPORIN A; INSULIN; METHYLPREDNISOLONE SODIUM SUCCINATE; MONOCLONAL ANTIBODY; OKT 3; ORAL ANTIDIABETIC AGENT; POLYCLONAL ANTIBODY; PREDNISONE; TACROLIMUS;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIABETIC NEPHROPATHY; FEMALE; GLUCOSE BLOOD LEVEL; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; HUMAN TISSUE; HYPEROSMOLAR COMA; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; KETOACIDOSIS; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SENSORIMOTOR NEUROPATHY; TREATMENT OUTCOME;

ACUTE DISEASE; ADULT; AGED; CHRONIC DISEASE; DIABETES MELLITUS; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; MEDICAL RECORDS; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT REFUSAL;

EID: 0032519418     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199802150-00014     Document Type: Article

References (27)

1. Starzl TE. Experiences in renal transplantation. Philadelphia: W.B. Saunders Co., 1964.
2. Hill CM, Rajkumar KV, Douglas JF, McEvoy J, McGeown MG. Glycosuria and hyperglycemia after kidney transplantation. Lancet 1974; 2: 490.
3. Arner P, Gunnarson R, Blomdahl S, et al. Some characteristics of steroid diabetes: a study in renal transplant recipients receiving high dose corticosteroid therapy. Diabetes Care 1983; 6: 23.
4. Vesco L, Busson M, Bedrossian J, Bitker MO, Hiesse C, Lang P. Diabetes mellitus after renal transplantation: characteristics, outcome and risk factors. Transplantation 1996; 61: 1475.
5. Roth D, Milgrom M, Esquenazi V, Fuller L, Burke G, Miller J. Posttransplant hyperglycemia. Transplantation 1989; 47: 278.
6. Mejia G, Arbelaez M, Henao JE, Arango JL, Garcia A. Cyclosporine-associated diabetes mellitus in renal transplants. Clin Transplant 1989; 3: 260.
7. Reid M, Gibbons S, Kwor D, Van Buren CT, Flechner S, Kahan BD. Cyclosporine levels in human tissues of patients treated for 1 week to 1 year. Transplant Proc 1983; 15: 2434.
8. Gillison SL, Bartlett ST, Curry DL. Inhibition by cyclosporine of insulin secretion: a β cell specific alteration of islet tissue function. Transplantation 1991; 52: 890.
9. Robertson RP. Cyclosporine-induced inhibition of insulin secretion in isolated rat islets and HIT cells. Diabetes 1986; 35: 1016.
10. Krausz Y, Wolheim CB, Siegal E, Sharp GWG. Possible role for calmodulin in insulin release: studies with trifluoperazine in the rat pancreatic islets. J Clin Invest 1980; 66: 603.
11. Ost L. Effects of cyclosporine on prednisolone metabolism. Lancet 1984; 1: 451.
12. Tze W, Tai N, Murase A, Tzakis A, Starzl TE. Effect of FK506 on glucose metabolism and insulin secretion in normal rats. Transplant Proc 1991; 23: 3158.
13. Tamura K, Fujimura T, Tsutmi T, et al. Transcriptional inhibition of insulin by FK506 and possible involvement of FK506 binding protein-12 in pancreatic β cell. Transplantation 1995; 59: 1606.
14. Pirsh JD, Miller J, Deirhoi MH, et al. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppresion after cadaveric renal transplantation: FK506 Kidney Transplant Study Group. Transplantation 1997; 63: 977.
15. Boudreaux JP, McHugh L, Canafax DM, et al. The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients. Transplantation 1987; 44: 376.
16. Friedman EA, Shyh T, Beyer M, Manis T, Butt KMH. Posttransplant diabetes in kidney transplant recipients. Am J Nephrol 1985; 5: 196.
17. Sumrani NB, Delaney V, Zhongkun D, et al. Diabetes mellitus after renal transplantation in the cyclosporine era: an analysis of risk factors. Transplantation 1991; 51: 343.
18. Tornatore KM, Biocevich DM, Reed KA, et al. Post-transplant diabetes mellitus and methylprednisolone pharmacokinetics in African-American and Caucasian renal transplant recipients. Clin Transplant 1995; 9: 289.
19. Kenny SJ, Aubert RE, Geiss LS. Prevalence and incidence of non-insulin dependent diabetes. In: Diabetes in America, 2nd ed [Publication No. 95-1468]. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1995: 47.
20. Gunnarson R, Arner P, Lundgren G. Steroid diabetes after transplantation: a preliminary report. Scand J Urol Nephrol 1977; 42 (suppl): 191.
21. Ramirez L, Koffler M, Rios J, et al. Steroid induced diabetes following renal transplantation: predisposing factors [Abstract]. Diabetes 1989; 38 (suppl 2): 77.
22. UNOS update: July/August 1996. Richmond, VA: UNOS, 1996.
23. Gulli G, Haffner S, Ferrannini E, DeFronzo RA. What is inherited in NIDD? Diabetes 1990; 39: A116.
24. Kobberling J, Tillil H, Lorenz HJ. Genetics of type 2A- and type 2B-diabetes mellitus [Abstract]. Diabetes Res Clin Pract 1985; 11 (suppl 1): S311.
25. Ekstrand AV, Eriksson JG, Gronhagen-Riska C, Ahonen PJ, Groop LC. Insulin resistance and insulin deficiency in the pathogenesis of posttransplantation diabetes in man. Transplantation 1992; 53: 563.
26. Eriksson J, Franssila-Kallunki A, Ekstrand A, et al. Early metabolic defects in persons at increased risk of developing non-insulin dependent diabetes mellitus. N Engl J Med 1989; 321: 337.
27. Von Kiparski A, Frei D, Uhlschmid G, Largiader F, Binswanger U. Post-transplant diabetes mellitus in renal allograft recipients: a matched-pair control study. Nephrol Dial Transplant 1990; 5: 220.